The electrophysiologic effects of intravenous verapamil (0.15 ml/kg) on retrograde atrioventricular (AV) nodal conduction were studied in 17 patients who had no evidence of supraventricular reentrant tachycardia, demonstrable dual AV nodal refractory period curves or accessory pathways. Using the His bundle electrogram, incremental ventricular pacing and the ventricular extrastimulus (V2) technique, the ventriculoatrial (VA), retrograde His-Purkinje system (V2H2) and AV nodal conduction (H 2A2) times were measured before and after treatment with verapamil.
the control period to 413.3 ± 66.8 ms (p < 0.0001) after verapamil. In the remaining three patients, verapamil had no effect on the onset of pacing-induced VA block. Following V2 during the control period, the retrograde His deflection (H 2) emerged from the local ventricular electrogram and retrograde atrial activation occurred via the His bundle in all patients. The control H 2A2 intervals ranged from 30 to 150 ms. After verapamil, retrograde AV nodal block (that is, H 2 but no A 2) occurred in 7 of 17 patients, and H 2A2 intervals were prolonged by a mean of 18.3 ± 5.5 ms (range 10 to 25) in another 6 patients. The H 2A2 intervals did not change in the remaining four patients after administration of verapamil.
The results show that verapamil exerts a depressant effect on retrograde AV nodal conduction in the majority of patients, including those with rapid conduction. This study, therefore, was undertaken to examine the response of retrograde AV nodal conduction to verapamil.
Methods
Patients. Seventeen consecutive patients with intact ventriculoatrial (VA) conduction who received verapamil were included in this study. There were 11 men and 6 women whose age ranged from 32 to 73 years (mean ± standard deviation [SO] 55.7 ± 10.5). The patients were studied because of syncope, dizziness or ventricular arrhythmias. Ten patients had arteriosclerotic heart disease, one had mitral valve prolapse and two had cardiomyopathy. The remaining four patients had no clinically detectable structural heart disease. Electrophysiologic studies were performed in the postabsorptive state. None of the patients were taking cardioactive medication at the time of this study. The nature of the procedure was explained and informed consent was obtained.
Electrophysiologic studies. Multipolar electrode catheters were introduced percutan eously under local anesthesia and were positioned with fluoroscopic guidance into the high right atrium , AV junction and right ventricle to record local electrical activit y or local electrical stimulation. All intracardiac electrograms (filtered at 30 to 500 Hz frequency ), three surface electrocardiograph ic leads and time lines were simultaneously displayed on a multichannel oscilloscope and recorded on magnetic tape for later reproduction . Programmed electrical stimul ation was done using a digital stimulator (Bloom Associates) , delivering rectangular impulses with adjustable amplitude and duration. During these studies, patient s were isolated electrically and all equipm ent was grounded at equipotential.
In all the patients the f ollowing electrical stimulation protocol was used: I) increm ental atrial pacing to achieve the anterograde AV nodal Wenckebach phenomenon; 2) anterograde refractory period determination using atrial basic drive (A lA I) followed by premature atrial stimulation (A z );
3) incremental ventricular pacing to achieve ventriculoatrial (VA) block ; and 4) retrograde refractory period studies using ventricular basic drive (SIS I or VIVI) followed by premature ventricular stimulation (Sz or Vz).
Definitions and measurements. Complete definition s for anterograde and retrograd e conduction times and refractory periods have been publish ed (14) . Pertinent definition s used in this report are described below .
The AH interval was measured from the onset of the low atrial electrogram to the beginning of the His (H) bundle potential.
Retrograde conduction: The VA (or SA) interval was measured from the corresponding stimulus artifact to the onset of the low right atrial deflection of the His bundle Pharmacokinetics of verapamil. Previou s studies have shown that a single intravenou s dose of verapamil has a biphasic mode of distribution in the body , the half-life of the initial phase being 18.5 to 30 minute s. The hemodynamic effects are of short duration , lasting approximately 10 minutes, but the electrophysiologic effect s, while maximal within 2 to 3 minutes of infusion, are still significant after 20 minutes (10). Verapamil plasma levels were not measured in this study . However , because the repeat protocol was completed within 15 minutes of administering verapamil, the results should reflect the electrophysiologic effect of the drug (16) (17) (18) (19) .
Statistical analysis. Mean values are expressed with corresponding standard deviation s. Compari son of mean values was done using the paired t test. Stati stical significance was defined at the 5% level.
Results
All patients were in sinus rhythm and had normal AH and HV intervals. Relevant data are described in detail below.
Anterograde conduction times and refractory periods. The effects of intravenou s verapamil on sinus cycle length, anterograde conduction time and refractory period s were similar to those previou sly publi shed (10) (11) (12) 18) . The mean control spontaneous sinus cycle length was 777.0 ± III ms (range 610 to 1,090), which prolonged to a mean of 818.2 ± 128 ms (range 670 to 1,120) after verapam il (prob-
The mean AH interval during sinus rhythm was 102.0 ± 23.5 ms (range 80 to 140), which prolonged to a mean of 137.3 ± 26.9 ms (range 100 to 190) after verapamil (p < 0.01). The HV interval during sinus rhythm had a mean value of 41.4 ± 5. 2 ms (range 35 to 50) before and 42.0 ± 5.0 ms (range 35 to 50) after verapamil (p = not significant). The atrial pacing cycle length that produ ced AV nodal Wenckebach phenomenon measured 359.4 ± 82.6 ms (range 300 to 600) during the control period , which increased to a mean of 432.9 ± 9 1. 1 ms (range 330 to 650) after verapamil (p < 0.001 ). The functional refracto ry period of the AV node before drug administration was 414.1 ± 54.0 ms (range 314 to 520). which increased to a mean of 470 ± 582 ms (range 400 to 580) after the drug (p < 0.001). The AV nodal effective refractory period could be measured in II of 17patients beforeand after administration of verapamil and was 318 ± 58.1 ms (range 240 to 410) and 374 ± 63.6 ms (range 300 to 480), respectively (p < 0.00 I). In the remaining six patients, the effecti ve refractory period of the atrium was reached before that of the AV node. The control effective refractory period of the atrium did not change significantly after administration of verapamil (239.3 ± 28.8 and 245.6 ± 27.3 ms during the control period and after verapamil , respectively).
Retrograde conduction times (Table 1) . For the entire group, the mean paced cycle length resulting in ventriculoatrial (VA) block during the control period was 337.0 ± 67.8 ms (range 260 to 520). After administration of verapamil, VA conduction was abolished in 2 patients (Cases 15 and 16), and in 12 patients (Cases 1,2,4 to 12 and 14), the mean cycle length that produced VA block increased from 305.0 ± 35.7 to 41 3.3 ± 66.8 ms (p < 0.0001 ) (Fig.   I ). In the remaining three patients (Cases 3,13 and 15), verapamil produced no detectable change.
During the control study, the mean value for the shortest VA intervals in these 17 patients was 167.7 ± 36.4 ms (range 110 to 240). Before drug administration, the VA intervals stayed constant in 3 patients (Cases 3,4 and II ), whereas lengthening of the VA interval was noted in the remaining 14 as the paced cycle length was shortened. The magnitude of change in the VA interval from longest to shortest paced cycle lengths with I:I response in these 14 cases ranged from 10 to 140 ms (mean 40.0 ± 34.2).
After administration of verapamil, the VA intervals could not be measured in two patients (Cases 16 and 17) because of the onset of complete VA block. The site of retrograde block and concealed conduction was the AV node, as suggested by intranodal delay and block of dissociated sinus beats. Four patients (Cases 3,9, 13 and 15) showed no change in either the shortest or the longest VA interval after verapami!. In the remaining II patients, the shortest and longest VA intervals increased by 20.4 ± II. 3 ms (range 10 to 40) and 27.7 ± 15.2 ms (range 10 to 60), respectively, after verapami!.
Retrograde refractory period studies (Table 1) . During the control period, the VzA z response in all patients was typical of retrograde conduction by way of the normal pathway, that is, the retrograde A z response was dependent on Hz activation. Progressive shortening in the VIVz intervals produced a progressive increase in VzA z. Within a certain range of VIV2, the retrograde His bundle potential (Hz) emerged from the local V2 electrogram, permitting separation of the retrograde His-Purkinje system time (SzH 2 or VzH z interval) from the retrograde AV nodal (HzA z) conduction time. The retrograde His-Purkinje system and AV nodal conduction responses to verapamil are shown separately in this report.
Retrograde AV nodal conduction . The control HzA z intervals were relatively short (:::;;50 ms) and constant in II patients (Cases 1 to II ), of medium duration (~55 but :::;;\00 ms) in 4 (Cases 12 to IS) and long (~100 ms) in the remaining 2 (Cases 16 and 17). None of our patients exhibitedretrograde block in the AV nodeduringventricular premature stimulation at any of the coupling intervals. After administration of verapamil , VA conduction during the basic drive (VIAl) remained intact in 15 patients and was abolished in 2 (Cases 16 and 17). In the latter two patients, it I   320  510  170  185  240  300  600  190 180  40  55  30  45  380 390 210 210  2 300  430  140  165  170  190  600  170 180 40 Blocked  20 Blocked 440 420 200 200  3 440  440  180  180  180  180  600  280 280  45  45  30  30  580 570 21 0 21 0  4  260  320  110  125  11 0  125  600  280 275 50  65  30  40  41 0 420 200 200  5 300  420  160  180  170  195  600  255 250  50 Bl ocked  40 Blocked 41 0 410 230 230  6  330  470  140  160  190  225  600  140 140  50  75  40  64  420 420 240 250  7  370  410  240  250  380  400  600  21 0 21 0 45  65  30  55  460 460 240 240  8 290  480  120  160  140  180  600  200 200  45 Bl ocked  30 Blocked 430 420 240 240  9 260  320  190  190  220  220  700  21 0 210  40  40  30  45  430 430 200 190  10  340  420  200  230  210  240  600  210 210  35 Blocked  50 Bl ocked 470 470 210 21 0  11  260  320  230  240  230  240  600  210 210 30  40  20  20  450 450 230 230  12 350  480  190  220  250  290  600  240 240 80  105  60  80  480 490 240 240  13  340  340  220  220  260  260  700  190 180  75  75  60  60  420 420 230 220  14 280  380  160  170  170  180  500  180 180  80 Bl ocked  70 Blocked 440 440 220 220  15  340  340  170  170  200  200  600  270 270 95  95  11 5 could be directly documented with V2 that the site of block was above the His bundle recording site. In 5 of the 15 patients with intact VIAl (Cases 2,5,8,10 and 14), the V 2 showed a retrograde block in the AV node (that is, H 2 but no A 2) (Fig. 2) . Another six patients (Cases 1,4,6,9 and 12) demonstrated prolongation of the H 2A2 interval by a mean of 18.3 ± 5.5 ms (range to to 25) after administration of verapamil. In the remaining four patients (Cases 3, 11,13 and 15), verapamil had no effect on H 2A2 conduction. Retrograde His-Purkinje system conduction. Verapamil produced no significant effect on this value. The longest S2H2 intervals before and after verapamil were 214.4 ± 39.3 ms (range 140 to 280) and 213.2 ± 38.8 ms (range 140 to 280), respectively. Similarly, the retrograde functional refractory period of the His-Purkinje system did not change significantly after verapamil, and the values were 444.7 ± 44.7 ms (range 380 to 560) before and 444.1 ± 43.4 ms (range 390 to 570) after, respectively, for all 17 patients. The effective refractory period of ventricular myocardium also did not change and the mean values were 221.8 ± 17.8 ms and 221.2 ± 19.3 ms, respectively, before and after verapamil.
Discussion
Effect of verapamil on retrograde AV nodal conduction. The data presented here suggest that verapamil consistently produces a depressant effect on ventriculoatrial (VA) conduction through the normal pathway (that is, AV node-His-Purkinje system). Because no direct depressant action of verapamil has been demonstrated on His-Purkinje system conduction times or refractoriness, the logical inference is that the observed changes were confined to the AV node (20) . The latter conclusion could also be directly documented in this study during ventricular premature stimulation, which showed that the conduction delay or block, or both, after administration of verapamil was always above the site of the His bundle recording. Verapamil also uniformly produced the expected increases in anterograde AV nodal conduction time and refractoriness (18) . In this study, no appreciable changes in atrial or ventricular refractoriness were observed after administration of verapamil.
In individual patients, the magnitude of depression in AV nodal conduction was not predictable. It was noted, however, that the two patients who developed complete VA block (AV dissociation) after verapamil had the longest H 2A2 intervals (l05 and 150 ms) before administration of the drug. In the remaining patients, the degree of depressant effect (delay or block) was comparable; that is, patients with short or medium range H 2A2 intervals showed a similar magnitude of change. Interestingly, of the four patients with no change in H 2A2 conduction, two had relatively short (40 and 45 ms) H 2A2 intervals and the remaining two had values in the medium range (75 and 95 ms).
Effect on AV nodal versus His-Purkinje conduction. Although the retrograde His deflection was not clearly identifiable during incremental ventricular pacing, the change in the VA intervals with incremental pacing after verapamil was most probably due to an increase in the AV nodal (HA) rather than the His-Purkinje system (SH) conduction time. This can be safely deduced from the following observations: l) no change in His-Purkinje system conduction times or refractory periods was noted after administration of verapamil in this study; and 2) patients who did not manifest any increase in the VA intervals afterthe drug (Cases 3,9,13 and 17) also did not demonstrate an increase in the HzA z intervals. Because blood levels were not measured during this study, one might argue whether blood levels in these four patients were sufficiently high. However, these patients manifested an appropriate increase in anterograde AV nodal conduction, which is a more significant manifestation of cardiac drug effect than the blood levels.
Electrophysiologic significance. A depressant response to verapamil in patients with long HzA z intervals is not surprising because in these cases, the retrograde conduction would be considered typically AV nodal, that is, long H zA2 intervals and onset of VA block at relatively long paced cycle lengths of 520 and 400 ms, respectively (14) . However, verapamil produced a similar depressant effect in 9 of 11 patients with short (:s; 50 ms) HzA z intervals. Accepting the prevailing view that the depressant effect of verapamil on the AV node is secondary to its calcium channel blocking properties, it would seem that the short H zA2 intervals are compatible with intranodal conduction. Therefore, one need not invoke the presence of AV nodal bypass tracts to explain the relatively rapid HA conduction in this group of patients (21, 22) .
A complete lack of depressant effect on H 2A2 conduction seen in four patients, however, is puzzling. One possible explanation is that the reflex sympathetic stimulation after administration of verapamil may have nullified the depressant effect of drug on the AV node (17-19) . However, the hypotension in these patients with verapamil or ventricular pacing, or both, was no greater than in the rest of the patients. Furthermore, no other evidence of excessive sympathetic stimulation, such as sinus acceleration and shortening of AH intervals (or lack of AH prolongation), was noted. Verapamil-or pacing-induced sympathetic stimulation, or both, therefore does not appear to be a rational explanation for fixed H 2Az intervals in these cases. Another possibility is that the lack of H 2A2 prolongation represents conduction by way of a complete AV nodal bypass (atrioHis) tract rather than the AV node (22) . Although this hypothesis is quite conceivable, it is noteworthy that control HA conduction times in two of these four patients cannot be considered rapid and thus, of themselves, are not suggestive of conduction by way of an AV nodal bypass tract. Perhaps the differences in responsiveness to verapamil in the anterograde and retrograde directions in these four patients are related to physiologic rather than anatomic factors that have been previously postulated and are, therefore, not discussed in detail here (23) (24) (25) (26) .
Clinical implications. Although patients with AV nodal reentrant tachycardia were specificially excluded from this study, the retrograde conduction patterns in 15 of the 17 patients (except Cases 16 and 17) were quite similar to those in patients with common AV nodal reentry (27) . In patients with common AV nodal reentry, verapamil is expected to produce a depressant effect on the anterograde limb of the circuit (the so-called slow pathway). The results of our study suggest that verapamil may abo produce a depressant effect on the retrograde fast pathway of the reentrant circuit.
